Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial

Authors

Institutions

Publication Details

Journal
The Lancet Respiratory Medicine
Published
2025-06-24
DOI
https://doi.org/10.1016/s2213-2600(25)00213-9
Citations
5
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
7.59
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial

David R. Spigel, Gavitt A. Woodard, Sylvie Van Hulst, David R. Gandara et al.
5 citations
The Lancet Respiratory Medicine
Lung Cancer Diagnosis and Treatment
7.59
article

Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial

David R. Spigel, Gavitt A. Woodard, Sylvie Van Hulst, David R. Gandara, J. Le Treut, Olivier Bylicki, Martin Reck, Firas Badin, Frank Griesinger, Adam J. Bograd, Johannes R. Kratz, Matthew A. Gubens, Ian C. Anderson, Laurent Greillier, G. Rousseau-Bussac, Florian Guisier, Petra Hoffknecht, Virginie Westeel, Michael J. Mann, David M. Jablons, John Crowley, Wangjian Zhong, Heiko von der Leyen, Clotilde Deldycke
article en
5 citations

Abstract

No abstract available for this paper.
The Lancet Respiratory MedicineVol. 13(10)
University of Kentucky HealthCare (US), Providence Regional Medical Center Everett (US), Inserm (FR), University of California, San Francisco (US), Yale University (US), Medizinische Hochschule Hannover (DE), Central Baptist Hospital (US), Intergroupe Francophone de Cancérologie Thoracique (FR), Sarah Cannon (US), Cancer Research And Biostatistics (US), Centre Hospitalier Universitaire de Poitiers (FR), Asklepios Klinik St. Georg (DE), Pius Hospital Oldenburg (DE), LungenClinic Grosshansdorf (DE), Université Marie et Louis Pasteur (FR), LaGrange College (US), University of San Francisco (US), University of California, Davis (US)
Openalex Percentile: Top 3%
Lung Cancer Diagnosis and Treatment
7.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.